Allele-specific induction of IL-1beta expression by C/EBPbeta and PU.1 contributes to increased tuberculosis susceptibility by Zhang, Guoliang et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2014-10-16 
Allele-specific induction of IL-1beta expression by C/EBPbeta and 
PU.1 contributes to increased tuberculosis susceptibility 
Guoliang Zhang 
Guangdong Medical College 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Bacterial Infections and Mycoses Commons, Immunity Commons, Immunoprophylaxis and 
Therapy Commons, and the Pathogenic Microbiology Commons 
Repository Citation 
Zhang G, Zhou B, Li S, Yue J, Yang H, Wen Y, Zhan S, Wang W, Liao M, Zhang M, Zeng G, Feng CG, Sassetti 
C, Chen X. (2014). Allele-specific induction of IL-1beta expression by C/EBPbeta and PU.1 contributes to 
increased tuberculosis susceptibility. Open Access Articles. https://doi.org/10.1371/
journal.ppat.1004426. Retrieved from https://escholarship.umassmed.edu/oapubs/2458 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Allele-Specific Induction of IL-1b Expression by C/EBPb
and PU.1 Contributes to Increased Tuberculosis
Susceptibility
Guoliang Zhang1,2, Boping Zhou1, Shaoyuan Li3, Jun Yue4, Hui Yang2, Yuxin Wen5, Senlin Zhan1,2,
Wenfei Wang1,2, Mingfeng Liao1,2, Mingxia Zhang1,2, Gucheng Zeng3, Carl G. Feng6,
Christopher M. Sassetti7,8*, Xinchun Chen1,2*
1Guangdong Key Lab of Emerging Infectious Diseases, Guangdong Medical College, Shenzhen, China, 2 Shenzhen Key Lab of Infection and Immunity, Shenzhen Third
People’s Hospital, Guangdong Medical College, Shenzhen, China, 3Department of Microbiology, Key Laboratory for Tropical Diseases Control of the Ministry of Education,
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China, 4Department of Clinical Laboratory, Shanghai Pulmonary Hospital, Tongji University, Shanghai,
China, 5Department of Chest Surgery, Shenzhen People’s Hospital, Jinan University, Shenzhen, China, 6Department of Infectious Diseases and Immunology, Sydney
Medical School, The University of Sydney, Sydney, Australia, 7Department of Microbiology and Physiological Systems, University of Massachusetts Medical School,
Worcester, Massachusetts, United States of America, 8Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America
Abstract
Mycobacterium tuberculosis infection is associated with a spectrum of clinical outcomes, from long-term latent infection to
different manifestations of progressive disease. Pro-inflammatory pathways, such as those controlled by IL-1b, have the
contrasting potential both to prevent disease by restricting bacterial replication, and to promote disease by inflicting tissue
damage. Thus, the ultimate contribution of individual inflammatory pathways to the outcome of M. tuberculosis infection
remains ambiguous. In this study, we identified a naturally-occurring polymorphism in the human IL1B promoter region,
which alters the association of the C/EBPb and PU.1 transcription factors and controls Mtb-induced IL-1b production. The
high-IL-1b expressing genotype was associated with the development of active tuberculosis, the severity of pulmonary
disease and poor treatment outcome in TB patients. Higher IL-1b expression did not suppress the activity of IFN-c-
producing T cells, but instead correlated with neutrophil accumulation in the lung. These observations support a specific
role for IL-1b and granulocytic inflammation as a driver of TB disease progression in humans, and suggest novel strategies
for the prevention and treatment of tuberculosis.
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Introduction
Tuberculosis (TB), a chronic bacterial disease caused by
Mycobacterium tuberculosis (Mtb), remains a major global health
problem that claims 1.4 million lives annually. Natural infection
with Mtb is initiated by the deposition of Mtb-containing aerosol
droplets onto lung alveolar surfaces, and infection at this site can
produce a wide spectrum of clinical outcomes. The vast majority
of immunocompetent individuals contain the pathogen and
remain indefinitely asymptomatic, a status defined as ‘‘latent’’
TB [1]. A smaller proportion of Mtb-infected people develop
active disease, most often characterized by a progressive
inflammatory pathology of the lung. The hematogenous dissem-
ination of Mtb can also result in disease at a variety of extra
pulmonary sites, commonly including bone and the central
nervous system [2].
The mechanisms controlling TB progression remain elusive.
Both Mendelian genetic susceptibilities in the IL-12 and IFN-c
axis [3,4], and the association of TB with HIV-mediated
lymphocyte depletion indicate that cell-mediated adaptive immu-
nity is critical for controlling mycobacterial growth and containing
disease. However, genetic association studies also commonly
identify single nucleotide polymorphisms (SNPs) in pro-inflamma-
tory innate immune mediators that are associated with TB
susceptibility and regulate cellular function, such as TLRs,
LTA4H, IL22, and IL6 [5,6,7,8,9,10]. These associations suggest
that disease progression may be determined at multiple levels in
human populations and that the inflammatory response could play
a decisive role.
As a potent proinflammatory cytokine, IL-1b plays an
important role in many inflammation-related diseases as well as
cancer. Accordingly, IL1B gene polymorphisms, especially func-
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tional SNPs -31 T.C (rs1143627) and -511 G.A (rs16944)
are associated with susceptibility to a number of diseases
[11,12,13,14]. IL-1b is also important in the pathogenesis of TB
in mice [15], and polymorphisms in the human IL1B gene have
been suggested to have differing effects on TB susceptibility.
Awomoyi reported the IL1B rs16944, but not +3953 T.C
(rs1143634) SNP, was associated with susceptibility to TB in a
Gambian population [16]. Kusuhara et al reported that three
SNPs in IL1B (rs1143629, rs1143643 and rs3917368) are
associated with TB susceptibility in a Japanese population [17].
Similarly, susceptibility to TB is associated with the polymorphic +
3953 region in the IL1B gene [18]. Using an oligochip-based
method, Sun et al genotyped two SNPs (rs1143627, rs16944) in a
small cohort of the Chinese Han population (98 TB patients and 65
healthy controls), and found that the rs1143627T allele was
associated with TB susceptibility [19]. On the contrary, a strong
protection conferred by IL1B +3953 T-allele-carrying genotypes
was observed in a Northwestern Colombian population [20]. While
these studies implicated several SNPs in IL1B gene were associated
with TB susceptibility, a conclusive role of IL1B SNPs has not yet
been established due to the small sample sizes and different ethnic
background in these studies. Furthermore, the mechanisms by
which these polymorphisms might act remain unclear.
Recent mechanistic studies in the mouse model have implicated
IL-1b mediated granulocytic inflammation as a potential driver of
TB progression [21,22,23]. IL-1b is a prototypical proinflamma-
tory cytokine that stimulates both local and systemic responses
[24], and this cytokine plays a complex dual role in chronic
infections. The production of IL-1b is important for the proper
development of antimicrobial adaptive immunity during the initial
stages of infection [25,26]. However, prolonged IL-1b production
promotes the continual recruitment of granulocytes to the lung,
induces the expression of additional inflammatory mediators such
as prostaglandin E2, and stimulates tissue-damaging metallopro-
teinases [27,28]. As a result, the production of this cytokine must
be repressed in chronically Mtb-infected animals to avoid
progressive pathology [21,29]. While, production of IL-1b
correlates with the severity of human TB disease [30,31], its
paradoxical activities in promoting both antimycobacterial immu-
nity and chronic tissue damage leave the ultimate contribution of
this cytokine to TB progression in human populations unclear.
In this study, we identified a genetic polymorphism (rs1143627)
in the promoter region of the IL1B gene that increases the C/
EBPb- and PU.1-dependent expression of the cytokine. The high-
IL-1b-expressing genotype is associated with increased risk of
active tuberculosis and poor clinical outcome. The observed
correlation between IL-1b production, neutrophil recruitment,
and TB susceptibility indicates a causative role for IL-1b-mediated
granulocytic inflammation in TB progression.
Results
IL1B promoter polymorphism is associated with
susceptibility to tuberculosis
Genetic variants in the IL1B gene, especially those in the
promoter region, can affect cytokine expression and have been
associated with susceptibility to inflammatory disorders [24,32]
and chronic infections [33,34]. Since TB is a disease of chronic
inflammation, we hypothesized that similar genetic variants might
alter susceptibility to this disease. To test our hypothesis, the
genotype distribution of 4 IL1B SNPs with potential regulatory
effects was first determined in healthy controls and TB patients
from a cohort in Shenzhen and then replicated in a Shanghai
cohort (Table 1). Among them, the following three SNPs were
located within the known promoter region, -31 T.C (rs1143627),
-511 G.A (rs16944), and -1473 G.C (rs1143623). The final
SNP, +7326 T.C (rs2853550), is located in the 3-UTR of IL1B
gene. The minor allele frequencies of all 4 SNPs were.10% and
were in Hardy-Weinberg equilibrium in both control groups (P.
0.05). However, only the frequency of rs1143627 was significantly
different between patients with active TB (TB, n= 1533) and
healthy controls (HC, n= 1445) in the Shenzhen cohort.
Specifically, a significantly higher frequency of the T allele at
rs1143627 was observed among patients with active TB,
compared with controls, indicating that this allele is associated
with an increased risk of tuberculosis (odds ratio [OR]= 1.20; 95%
confidence interval [CI], 1.09–1.33; P=0.0004). At the genotype
level, carriage of the IL1B rs1143627T allele increased the
apparent risk of active TB (OR=1.35; 95% CI, 1.14–1.59;
P=0.0005, dominant model). TT and TC genotypes also showed
increased TB susceptibility compared to CC genotype using an
additive model (OR=1.44; 95%CI, 1.18–1.76; P=0.0004; and
OR=1.30; 95%CI, 1.09–1.55; P=0.004) (Table 2).
The association of rs1143627 with tuberculosis was replicated in
an independent Shanghai cohort. In this group the T allele was
associated with TB susceptibility using a multiplicative model, with
an adjusted OR of 1.40 (95% CI, 1.10–1.77, P= 0.007). Using an
additive model the T allele was estimated to impart a 97%
increase in risk (OR=1.97; 95% CI, 1.20–3.23; P= 0.006)
(Table 3). These observations from two large independent cohorts
were similar and consistent with the reported distribution of
rs1143627 and rs16944 alleles in separate small cohort of Chinese
TB patients and healthy controls [35]. When we pooled the
Shenzhen and shanghai data together (1799 cases and 1707
controls) for statistical analysis, the effect of rs1143627T was even
stronger in all genetic models (multiplicative, additive, dominant
and recessive, Table S1) than in either cohort alone. Thus, we
conclude that the T allele of IL1B SNP rs1143627 is associated
with susceptibility to active TB in the Chinese population.
While TB is primarily a disease of the lung, dissemination of the
bacterium can also result in pathology at a variety of different
tissue sites. To understand if the rs1143627 SNP differentially
affected pulmonary versus extrapulmonary disease, we further
investigated whether the distribution of rs1143627 alleles differed
in patients suffering from distinct manifestations of TB. As shown
Author Summary
IL-1b is important for the initial establishment of antimi-
crobial adaptive immunity, but prolonged IL-1b expression
can also cause progressive immunopathology during M.
tuberculosis infection. The paradoxical activities of IL-1b in
promoting both antimycobacterial immunity and chronic
tissue damage have left the ultimate contribution of this
cytokine to TB progression in human populations unclear.
In this work, we address the role of IL-1b-mediated
inflammation using a combination of human genetics
and molecular biology, and suggest that exuberant IL-1b
responses are causatively associated with TB progression
and poor treatment outcome in humans. This work
furthers our understanding of the immunological factors
that underlie TB disease and provide a strong rationale for
the development of specific anti-inflammatory adjunctive
therapies that could improve the long-term outcome of TB
treatment. In addition, these insights inform the design of
future TB control efforts that include the rational design of
disease-preventing vaccines and genotype-targeted deliv-
ery of TB chemotherapy.
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in Table 4, the rs1143627T allele is significantly associated with
both pulmonary TB (PTB, OR=1.17; 95% CI, 1.06–1.30;
P=0.003) as well as extrapulmonary disease (ETB, OR=1.78;
95% CI, 1.32–2.39; P,0.0001) using a multiplicative model.
However, the frequency of the rs1143627T allele was significantly
higher in patients with extrapulmonary TB than in those with
pulmonary disease (P=0.005). Thus, among TB patients,
individuals carrying rs1143627T allele are more prone to develop
extrapulmonary TB than those without (OR=1.53, 95% CI,
1.14–2.05, multiplicative model).
IL1B polymorphism is associated with more severe TB
disease
The proinflammatory activity of IL-1b suggested that the
rs1143627 polymorphism might affect the inflammatory response
to Mtb, which could be exhibited at either systemic or local levels.
No difference in erythrocyte sedimentation rate (ESR) or C-
reactive protein (CRP) levels were apparent among pulmonary TB
patients carrying different rs1143627 genotypes (TT, TC, CC)
(Fig. S1). However, using high-resolution computed tomography
(HRCT), we were able to directly quantify lung damage in these
patients using a score based on radiographic manifestations
including the presence of nodules, cavities, and bronchial lesions
[36,37]. A total of 453 out of 1432 patients with primary
pulmonary TB received an HRCT score before anti-TB
treatment. Among these individuals, the HRCT scores were
significantly higher in patients carrying rs1143627TT genotype
than those with rs1143627CC genotype (Fig. 1A). Even 2 years
after the completion of anti-TB treatment, patients (n = 53) of the
rs1143627TT genotype still displayed significantly higher HRCT
scores than those carrying rs1143627CC, suggesting that the
rs1143627 polymorphism is associated with long-term lung
damage and disease outcome (Fig. 1C). In contrast, no difference
of HRCT score was found in patients carrying different genotypes
of rs16944 (Fig. 1B and D), an IL1B SNP that is associated with
the risk of developing active TB in the Gambian population [16],
but not in our current study. Taken together, these results
indicated that the rs1143627T allele is associated with more severe
pulmonary TB and the expression of extrapulmonary disease.
The rs1143627T allele increases IL-1b production, but not
IL-Ra expression
Located at position -31 from the transcriptional start site, SNP
rs1143627 is in the promoter region of IL1B gene. Previous
reports indicated that rs1143627 affects transcription of IL-1b in
response to lipopolysaccharide [38]. To determine whether this
polymorphism affects gene expression in response to Mtb
stimulation, we assessed IL-1b expression in CD14+ monocytes
isolated from healthy controls carrying different rs1143627
genotypes in response to heat-killed Mtb or the 19 kDa lipoprotein
derived from this bacillus. In response to both stimuli, monocytes
isolated from individuals carrying rs1143627TT and TC geno-
types produced significantly higher amounts of IL1B protein
(Fig. 2A) and mRNA (Fig. 2C) than those carrying the CC
genotype. Since the bioactivity of IL-1b also involves the
antagonistic effects of IL-1Ra, we assessed the concentration of
IL-1Ra in the culture supernatant and IL1RN mRNA cell lysates.
As shown in Fig. 2B and D, no significant differences were
observed in IL-1Ra expression upon Mtb lysate stimulation among
different rs1143627 genotypes. Together, these results suggest that
the rs1143627T allele specifically increased the amount of
bioactive IL-1b produced by Mtb stimulation.
The rs1143627T allele does not impair the anti-
mycobacterial adaptive immune response, but promotes
neutrophil infiltration to the lung
IL-1b is recognized to play an important role in shaping
adaptive immunity, especially Th17 cell responses [39,40]. To
understand if the rs1143627T allele could promote TB disease by
inhibiting the expression of adaptive immunity, we investigated
whether this polymorphism altered the production of Mtb antigen-
specific IFN-c or IL-17A, the hallmark cytokines of Th1 and Th17
cells, respectively. PBMC isolated from healthy controls carrying
different rs1143627 genotypes were cultured in the presence of
heat-killed Mtb and the production of IFN-c and IL-17A were
compared. Consistent with our previous results with purified
monocytes, we found that PBMC from individuals carrying
rs1143627 TT and TC genotypes produced more IL-1b than
those from individuals carrying the CC genotype (Fig. 3A). The
rs1143627TT PBMC also produced slightly higher levels of IFN-c
and similar levels of IL-17A as rs1143627 CC cells (Fig. 3, B and
C). The increased production of IFN-c was a result of IL-1b
secretion, as IFN-c and IL-1b secretion were highly correlated in
PBMC cultures and IFN-c production could be inhibited by the
addition of a blocking antibody to IL-1b (Fig. S2).
The effect of rs1143627 on the production of IFN-c-producing
cells was further investigated in a large cohort of pulmonary TB
patients. Mtb antigen-specific IFN-c production by PBMCs was
detected by using a previously established IFN-c Elispot assay that
employs either ESAT-6 protein or an ESAT-6/CFP-10 peptide
pool as a stimulant [41,42]. Patients carrying the rs1143627TT
genotype had significantly higher numbers of Mtb antigen-specific
IFN-c spot forming cells (SFCs) than those carrying the CC
genotype (Fig. 3, D and E). In contrast, the numbers of IFN-c
Table 1. Characteristics of patients with active TB and healthy controls in multiple cohorts.
Cohort Subgroup No. Age, Years (mean±SD) Sex (Male:Female)
Shenzhen cohort
Healthy controls — 1445 36.84619.71 882:563
Active TB Pulmonary TB 1432 37.08614.17 920:512
Extrapulmonary TBa 101 34.69612.68 60:41
Shanghai cohort
Healthy controls — 262 39.84610.43 140:122
Active TB Pulmonary TB 266 41.72614.05 147:119
aIncluding tuberculous lymphadenitis (n = 62), tuberculous meningitis (n = 13), and osteoarticular tuberculosis (n = 26)
doi:10.1371/journal.ppat.1004426.t001
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SFCs were not different among patients carrying different rs16944
genotypes (Fig. S3). Thus, the TB-associated rs1143627T allele
was associated with an augmentation of the canonical antimyco-
bacterial response. We conclude that the susceptibility of
individuals carrying the rs1143627T allele is unlikely to be the
result of a failure to respond to mycobacterial antigen.
Another primary effect of IL-1b is the recruitment of
neutrophils, a process that can exacerbate TB pathogenesis in
animal models [21,22,23]. To investigate whether this cytokine
could play a similar role in human TB, we simultaneously
measured the level of IL-1b and the number of neutrophils in
broncheoalveolar lavage fluid (BALF) from patients with active
pulmonary TB. A significant correlation between the level of IL-
1b and the number of recruited neutrophils was found (r = 0.828,
P,0.0001) (Fig. 3F). Thus, the increased production of IL-1b
associated with the rs1143627T allele could promote lung damage
and TB progression by stimulating granulocytic inflammation.
SNP rs1143627 influences C/EBPb and PU.1 binding to
IL1B promoter
The rs1143627 defines a T.C mutation at the -31 position of
the IL1B promoter. We used electrophoretic mobility-shift
analysis (EMSA) to determine if this polymorphism altered protein
binding to this promoter region. Synthetic allele-specific oligonu-
cleotides representing the polymorphic rs1143627 sites were
incubated with nuclear protein extracts from human monocytic
U937 cells stimulated without or with killed Mtb lysate. There was
no difference in binding activity between rs1143627T oligonucle-
otide (T Probe) and rs1143627C oligonucleotide (C Probe) when
U937 were not stimulated with Mtb lysate (Fig. 4A). Previous Mtb
stimulation of these cells induced the formation of a DNA binding
complex on the rs1143627T oligonucleotide (‘‘complex 1’’,
Figure 4B). In contrast, Mtb exposure induced less complex 1
formation on the rs1143627C oligonucleotide (Fig. 4B, lane 2 and
6; Fig. 4C). Furthermore, complex 1 formation on radiolabelled
rs1143627 was specifically blocked by competition with the
unlabelled oligonucleotide (Fig. 4B, lanes 3, 4, 7, and 8). These
results indicated that the binding of one or more proteins to the
IL1B promoter region was altered by rs1143627 polymorphism,
which could cause the observed difference in IL-1b expression that
was associated with these genotypes.
Bioinformatics-based prediction analysis using alibaba and
match algorithm (http://www.gene-regulation.com) and previous
studies of the IL1B promoter region indicated that transcription
factors C/EBPa, C/EBPb, PU.1, TBP and SP1 are involved in the
regulation of IL1B gene expression and have the potential to bind
in the polymorphic region [43,44]. To determine if these proteins
were part of the rs1143627-modulated complex 1, we conducted
supershift experiments using antibodies against each transcription
factor. Addition of antibodies against C/EBPb and PU.1, but not
antibodies against RSRFC4, C/EBPa, TBP or SP1, to the
rs1143627T oligonucleotide binding reactions resulted in shift of
complex 1 to a higher molecular weight species (Fig. 4D). Thus,
the protein complex formed on the rs1143627-containing region
includes PU.1 and C/EBPb, suggesting that the T.C polymor-
phism could alter IL-1b expression by influencing the binding of
transcription complexes that contain these factors.
Expression of PU.1 and C/EBPb is induced by Mtb and
temporally-correlated with IL-1b expression
To determine if C/EBPb and PU.1 are produced in a manner
that is consistent with the proposed role in IL-1b regulation, we
quantified the expression of all three genes in the monocyte-like
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U937 cells after stimulation with heat killed Mtb or infection with the
live attenuated strain of Mtb, H37Ra. Consistent with previous
reports, both stimuli induced IL1BmRNA expression (Fig. 5A).More
importantly, we foundMtb exposure also induced the expression ofC/
EBPB (Fig. 5B) and PU.1 (Fig. 5C), but no significant difference was
observed in TBP expression (Fig. 5D). Furthermore, the mRNA level
of IL1B was significantly correlated with that of both C/EBPB
(r = 0.887, P,0.0001, Fig. 5E) and PU.1 (r= 0.811, P=0.0001,
Fig. 5F), and not correlated with TBP expression (r=0.314,
P=0.236, Fig. 5G). The induction of PU.1 and C/EBPB mRNA
expression occurred earlier after stimulation than IL1B (Fig. 5H-K),
which is consistent with a role for PU.1 and C/EBPb in regulating the
IL1B promoter in response to Mtb infection.
PU.1 and C/EBPb differentially transactivate IL1B
promoter variants determined by the rs1143627
polymorphism
To assess the role of PU.1 and C/EBPb in Mtb-induced IL1B
transcription, we investigated whether ectopic PU.1 and C/EBPb
expression affects IL1B promoter activity in HeLa cells. As shown
in Fig. 6A, transfection of a reporter plasmid containing a 1371 bp
fragment of the human IL1B promoter (21292 to +79) produced
very low luciferase levels. However, cotransfection of the IL1B
promoter plasmid with PU.1 or C/EBPb expression plasmids
significantly enhanced luciferase levels, and cotransfection of all
three plasmids further increased promoter activity (Fig. 6A).
Expression levels of PU.1 and C/EBPb were similar when
transfected either individually or in combination (Fig. 6C).
siRNA knockdown studies verified the contribution PU.1 and
C/EBPb in Mtb-induced IL1B transcriptional activity in this
transfection system. The expression of both transcription factors
could be partially inhibited by siRNA transfection (Fig. 6C).
Knockdown of either protein significantly inhibited the Mtb-
induced IL1B promoter activity (Fig. 6B). Simultaneous knock-
down had an additive effect (Fig. 6B), consistent with the
collaborative activity observed in co-transfection experiments
(Fig. 6A). Thus, these transcription factors simultaneously con-
tribute to IL1B promoter activity in HeLa cells.
Figure 1. SNP rs1143627 is associated with the severity of pulmonary TB disease. (A and B) The HRCT scores were determined in a total of
453 patients with pulmonary TB before initiation of anti-TB chemotherapy. The HRCT scores in patients carrying different rs1143627 genotypes (A) or
rs16944 genotypes (B) were compared. (C and D) The HRCT scores were determined in 53 of 453 patients who have performed HRCT examinations
before and 2 years after completion of anti-TB chemotherapy. The HRCT scores [before (pre-) and 2 years after (post-) initiation of treatment] in
patients carrying different rs1143627 genotypes (C) or rs16944 genotypes (D) were compared. Differences between groups were compared with the
ANOVA/Newman-Keuls multiple comparison test. *, p,0.05; **, p,0.01; ns, not significant.
doi:10.1371/journal.ppat.1004426.g001
Allele Affects TB through Regulating IL-1b
PLOS Pathogens | www.plospathogens.org 6 October 2014 | Volume 10 | Issue 10 | e1004426
We then utilized this reporter assay to determine if altered PU.1
and/or C/EBPb transactivation could account for rs1143627
allele-specific regulation of IL1B gene expression. When -31 T.C
alterations were introduced into the IL1B promoter we observed
no difference in basal transcriptional activity in HeLa cells.
However, upon co-transfection with PU.1, C/EBPb, or both, the
T allele produced significantly higher luciferase activity than the C
variant (Fig. 6A). The degree of increased activity observed for the
rs1143627 T allele was similar to that observed in primary
monocytes and PBMC (Fig. 2 and Fig. 3A). Taken together, these
results indicate that the SNP rs1143627 alters a cis-regulatory
element in the IL1B gene that alters C/EBPb- and PU.1-
dependent expression of IL1B and susceptibility to TB.
Discussion
Proinflammatory cytokines, such as IL-1b can play complex and
dichotomous roles during chronic infections. This cytokine is
initially required to prime the anti-mycobacterial immune
response [25,26,45], and may also promote resistance to initial
infection through the induction of epithelial antimicrobial peptides
[46]. However, the prolonged production of this cytokine must be
restrained to prevent chronic tissue damage [21]. Similarly
complex roles for proinflammatory pathways have been described
during a variety of viral and bacterial infections [47,48,49]. As a
result, the production of these cytokines often correlates with the
severity of human disease, but their complex biological activities
make it difficult to determine if this expression is causing pathology
or limiting it.
In this study, we define a mechanistic link between a
polymorphism in the promoter of the IL1B gene and the severity
of TB disease, which implies a causal relationship between the
expression of this cytokine and the progression of pathology. A
similar association between high IL1B expressing genotypes and
inflammatory diseases has been observed in a number of previous
studies. Associations between TB and IL1B polymorphisms at -
511G.A, +3953T.C, and +3962T.C have been reported in a
variety of populations [16,20,50,51,52], although our study is the
first to describe a link between high Mtb-induced IL-1b
production, inflammation, and TB disease. The specific IL1B
promoter allele (rs1143627T) that was associated with TB in our
large cohort was previously reported to be enriched in a smaller
study of Chinese TB patients [35]. Indeed, this allele is also
associated with other diseases that involve IL-1b-dependent
inflammation or cell death, such as influenza [53], keratoconus
[54,55], and coronary artery disease [56]. Thus, it appears that TB
susceptibility can be determined by similar mechanisms to those
that underlie other inflammatory diseases of diverse etiology.
We found that a single base change in the IL1B promoter
increased the synergistic activity of the C/EBPb and PU.1
Figure 2. The rs1143627 polymorphism affects IL-1b production by monocytes upon Mtb stimulation. CD14+ monocytes were isolated
from PBMCs of healthy controls carrying different rs1143627 genotypes (TT, n = 24; TC, n = 24; CC, n = 24). Purified CD14+ monocytes were cultured in
the absence or presence of heat-killed Mtb lysate (20 mg/mL) or Mtb 19 kDa lipoprotein (0.5 mg/mL,). (A and B) The concentrations of IL-1b (A) and IL-
Ra (B) in the culture supernatant were determined by ELISA after incubation for 24 h. (C and D) The IL1B (C) and IL1RN (D) mRNA levels were
determined using SYBR Green-based real-time qPCR after incubation for 24 h, and the data was expressed as mRNA copy number relative to house
keeping gene GAPDH. Differences between groups were compared with the ANOVA/Newman-Keuls multiple comparison test. *, p,0.05; **, p,0.01.
doi:10.1371/journal.ppat.1004426.g002
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transcription factors leading to increased IL-1b expression in
monocytes and PBMC. These two transcription factors are known
to act in a coordinated manner to drive macrophage differenti-
ation [57], and our studies suggest they also promote the effector
functions of these cells. Individuals carrying the high-IL-1b-
producing rs1143627T allele were more prone to develop active
TB, to have severe pathology in the lung, and to harbor
extrapulmonary lesions. The association between IL-1b produc-
tion and severe TB disease is consistent with our recent finding
that NLRP3 inflammasome dependent IL-1b enhances neutrophil
recruitment and exacerbates pulmonary pathology in mice
infected with Mtb [21]. In the chronically-infected mouse, IL-1b
Figure 3. rs1143627T-induced IL-1b has little effect on Mtb-specific lymphocyte responses, but IL-1b correlates with neutrophil
recruitment to the lung. PBMCs from healthy controls carrying different rs1143627 genotypes (TT, n = 24; TC, n = 24; CC, n = 24) were cultured in
the absence of Mtb lysate (20 mg/mL) for 48 h. (A-C) The concentrations of secreted IL-1b (A), IFN-c (B) and IL-17A (C) were determined by ELISA. (D
and E) Mtb antigen (ESAT-6 protein, or ESAT-6/CFP-10 peptide pool) specific IFN-c production by PBMCs from patients with PTB carrying different
rs1143627 genotypes was quantified by ELISPOT assay. Data were expressed as the number of IFN-c SFCs per 26105 PBMCs of each subjects.
Differences between groups were compared with the ANOVA/Newman-Keuls multiple comparison test. (F) Correlation analysis between the levels of
IL-1b and the number of neutrophils in the BALF. The coefficient r and P values are indicated. *, p,0.05; **, p,0.01.
doi:10.1371/journal.ppat.1004426.g003
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activity is restrained at a posttranslational level through the nitric
oxide (NO)-dependent nitrosylation of NLRP3 [21], an essential
component of the inflammasome complex that processes pro-IL-
1b into its active form. As this regulatory pathway has also been
described in human cells [58], the processing of rs1143627T-
induced pro-IL-1b into its bioactive form is likely mediated either
by residual NLRP3 activity or through inflammasome-indepen-
dent processes.
Two general mechanisms could account for the TB suscepti-
bility that is associated with increased IL-1b expression; inhibition
of specific antimicrobial immunity or exacerbated inflammatory
tissue damage. The former hypothesis is unlikely to explain our
current observations, as IFN-c and IL-17 responses were either
unchanged or enhanced in the TB susceptible individuals. The
correlation that we observed between IL-1b, IFN-c and TB
disease supports the emerging view of IFN-c as a poor correlate of
Figure 4. SNP rs1143627 variant affects C/EBPb and PU.1 binding to the IL1B promoter. (A and B) Nuclear extracts were prepared PMA-
differentiated U937 cells stimulated without (A) or with (B) Mtb lysate (20 mg/mL) for 24 h. Nuclear extracts were incubated with T-probe (lanes 1–4)
or C-probe (lanes 5–8) in the absence or presence of unlabelled competitors and subjected to EMSA. (C) The relative abundance of complex 1 bound
to T probe or C probe in (B) quantified by densitometry. Data are shown as the mean 6 SEM, and differences between groups were compared with
unpaired t tests. (D) Nuclear extracts prepared from (A) were incubated with T-probe in the absence (lane 2) or presence of antibodies against
transcription factors including ZEB1, MEF2, C/EBPa, C/EBPb, PU.1, TBP, and SP1 (lanes 4–10). Anti-C/EBPb (lane 7) and anti-PU.1 (lane 8) supershift the
DNA-protein complex 1. *, p,0.05.
doi:10.1371/journal.ppat.1004426.g004
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protective immunity [59]. Mtb antigen-specific IFN-c produc-
tion by Th1, multifunctional Th1, or Th1/Th17 cells, is
associated with clinical severity and bacterial load in TB
patients, and not protective immunity [36,60,61]. Instead, the
significant correlation we observed between IL-1b levels and
the number of neutrophils in BALF of patients with active TB
supports a specific role for granulocytic inflammation in
promoting the progression of TB disease. This model is
consistent with the pathological role played by neutrophil
recruitment in a number of TB-susceptible mouse strains
[22,62,63], and the predominance of this cell type in the BALF
of humans with active TB [29,64].
The high IL-1b expressing rs1143627TT genotype was
associated with the severity of lung pathology in TB patients both
before and after anti-tuberculosis treatment. This finding is
consistent with the poor treatment response of individuals with a
high frequency of IL-17/IFN-c double-producing cells [61], which
our studies suggest as a possible marker of IL-1b production
(Fig. 3). These observations suggest that sustained IL-1b produc-
tion causes persistent lung damage that could contribute to the
permanently decreased lung function observed in patients with
advanced and/or recurrent TB [65]. Thus, anti-inflammatory
treatments targeted to the IL-1 pathway could be a useful adjunct
therapy to mitigate the long-term pulmonary impairment caused
Figure 5. C/EBPB and PU.1 expression induced by Mtb temporally correlates with IL1B expression. (A-D) SYBR Green-based real-time qPCR
assay for the gene expression of IL1B (A), C/EBPB (B), PU.1 (C), and TBP (D) by differentiated U937 cells in response to Mtb lysate (20 mg/mL) or H37Ra
infection (MOI = 10). The data are expressed as mRNA copy number relative to the house keeping gene GAPDH. Differences between groups were
compared with the ANOVA/Newman-Keuls multiple comparison test. (E-G) Correlation analysis between the C/EBPB (E), PU.1 (F), or TBP (G) expression
and IL1B expression. The coefficient r and P values are indicated. (H-K) Dynamic change of IL1B (H), C/EBPB (I), PU.1 (J) and TBP (K) expression by
differentiated U937 upon stimulation with Mtb lysate (20 mg/mL). *, p,0.05; **, p,0.01.
doi:10.1371/journal.ppat.1004426.g005
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by Mtb infection, particularly for individuals of high IL-1b-
expressing genotypes.
Materials and Methods
Ethics statement
All protocols for this study were reviewed and approved by the
Research Ethics Committee of Shenzhen Third People’s Hospital
(No. 2012–003), and conducted according to the Declaration of
Helsinki. The use, for research purposes, of excess BALF leftover
from clinically indicated bronchoscopies was deemed exempt from
a requirement for informed consent beyond the consent normally
obtained for this clinical procedure. The Research Ethics
Committee approved the collection of peripheral blood exclusively
for research purposes with the written informed consent of all
participants.
Subjects and samples
Three case-control cohorts were used in this study to investigate
the association between IL1B gene polymorphisms and suscepti-
bility to TB. All subjects were genetically unrelated members of
the Chinese Han population. The Shenzhen experimental cohort
involved 1533 patients with active TB and 1445 healthy controls,
which have been used in our previous IL6 polymorphism
study[10]. Of the 1533 patients, 1432 were diagnosed with
pulmonary TB (PTB), and 101 were with extrapulmonanry TB
(ETB) including tuberculous lymphadenitis (n = 62), tuberculous
meningitis (n = 13), and osteoarticular TB (n= 26). The Shanghai
cohort was used for validation and consisted of 266 PTB patients
and 262 controls, which has been used for a previous genetic study
on IL-17F polymorphisms and TB susceptibility [66]. The
diagnosis of tuberculosis was based on clinical symptoms,
radiological evidence, and findings from Mtb examination as
described previously [10,67]. Healthy controls with normal chest
radiograph findings and without a clinical history of TB were
recruited. The characteristics of the study population are shown in
Table 1. The whole blood samples were store at 280uC after
collection for DNA extraction. Peripheral blood mononuclear cells
(PBMCs) were isolated from whole blood through density gradient
centrifugation over Ficoll-Hypaque as described elsewhere [68]
and stored in nitrogen. The broncho-alveolar lavage fluid (BALF)
was collected from Mtb culture confirmed pulmonary TB patients
(n = 57) before initiation of anti-TB chemotherapy.
SNP selection and genotyping
Genomic DNA was prepared from peripheral whole blood
according to the standard protocols of QIAamp DNA Blood Mini
kit (Qiagen, Hilden, Germany) as described previously[10]. Since
we were particularly interested in SNPs with regulatory activity,
we focused on SNPs located in putative transcription factor
binding sites and microRNA target sites. To search for functional
SNPs, we referred to Jaspar, UniPROBE, TRANSFAC, and
Figure 6. Allele-specific effects of rs1143627 are mediated through PU.1 and C/EBPb. (A) IL1B promoter luciferase reporter plasmids
carrying rs1143627 T or C allele were transfected into HeLa cells, with or without co-transfecting PU.1- or C/EBPb-expressing plasmids. Luciferase
activities of HeLa cells were determined and normalized to Renillla luciferase activities. (B) HeLa cells cotransfected with the T-allele IL1B promoter
luciferase reporter plasmids, PU.1- and C/EBP-b- expressing plasmids were infected with PU.1, C/EBPb, or control siRNA-carrying lentiviral vector
constructs. Luciferase activities of HeLa cells were determined and normalized to Renillla luciferase activities. Differences between groups were
compared with the ANOVA/Newman-Keuls multiple comparison test. (C) Western-blotting assay shows the expression of PU.1 or C/EBPb after
transfection or siRNA knockdown using monoclonal antibodies against PU.1 and C/EBPb. **, p,0.01, ***, p,0.001.
doi:10.1371/journal.ppat.1004426.g006
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PITA databases, then calculated the binding score of alleles to
transcription factor, or the minimum hybridization energy and
thermodynamics to microRNA as described [9]. Three SNPs in
the promoter (rs1143627 T.C, rs16944 G.A, rs1143623 G.C)
and one in 3-UTR (rs2853550 T.C) of the IL1B gene were
genotyped using the MassARRAY system (Sequenom, San Diego,
CA) as described elsewhere [9,10]. The relative height (intensity)
of the peaks and the signal-to-noise (SNR) ratio were analyzed
using Caller software to call genotypes in real-time. Typer software
can apply cluster analysis to the genotype calls assigned by the
Caller software. After cluster analysis, manual curation of spectra
was performed to further validate the outcome. Assays with low
call rates (,90%) were discarded or redesigned, i.e., all assays
shown in this study have a call rate of.90%.
HRCT examination and scoring
HRCT were performed at 10 mm section interval (120 kV, 50–
450 mAs), (1 mm slice thickness, 1.5s scanning time) with a
window level between 2550 and 40 Hounsfield Units (HU) and
window width between 300 and 1600 HU using the Toshiba
Aquilion 64 CT Scanner (Toshiba, Tokyo, Japan). HRCT scans
were analyzed two independent chest radiologists and final
conclusions on the findings were reached by consensus. The
arbitrary scores were based on the percentage of lung parenchyma
abnormality as previously described [36,37].
Cell preparation and cultures
Human monocytic cell lines U937 (ATCC CRL 1593) and
HeLa cells (strain S3) were cultured in antibiotic-free Dulbecco’s
modified Eagle medium (DMEM) containing 10% fetal bovine
serum (FBS) (Hyclone, Logan, UT, USA). After differentiation in
the presence of phorbol 12-myristate 13-acetate (PMA, 20 ng/ml)
for 24 hours, U937 cells were rested in fresh complete medium for
24 h before further stimulation. The differentiated U937 cells were
exposed to heat-killed M. tuberculosis lysate (20 mg/mL), or live
Mtb H37Ra strain at a multiplicity of infection of 10:1. The cells
were harvested after additional 24 hours and used for gene
expression assays or nuclear protein binding activity assays.
Primary monocytes were isolated from PBMCs of 72 healthy
controls (n = 24 for each rs1143627 genotype) by positive selection
using magnetic CD14 MicroBeads (Miltenyi Biotech, Germany)
according to the manufacturer’s instructions. Purified CD14+
monocytes and PBMCs were transferred into a 96-well plate in
serum-free AIM-V medium (Gibco, Carlsbad, CA, USA), with
26105 cells/well in the absence or presence of heat killed Mtb
lysate (20 mg/mL) or Mtb 19 kDa lipoprotein (0.5 mg/mL; Lionex
GmbH, Braunschweig, Germany). The cells were harvested after
24 h or 48 h and used for gene expression assays, and the
supernatant was collected to determine cytokine (IL-1b, IL-1Ra,
IFN-c, and IL-17A) production using ELISA.
Measurement of genes expression by qRT-PCR
Total RNA extraction was performed with the RNAeasy Mini
kit (Qiagen, Valencia, CA), and residual DNA was digested using
RNAse-free DNAse (Qiagen). cDNA was synthesized using an
oligo-dT primer and SuperScript II reverse transcriptase (Invitro-
gen, Carlsbad, CA). Gene expression was measured using a
previously described SYBR Green-based real-time quantitative
PCR [69]. For all assays, target genes were normalized against the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) level. The
qPCR primers were designed as follows: for the IL1B gene:, 5’-
TTCTTCGACACATGGGATAACG-3’ (forward) and 5’-
TGGAGAACACCACTTGTTGCT-3’ (reverse); for the IL1RN
gene: 5’-GGAAGATGTGCCTGTCCTGT-3’ (forward) and
5’-TCTCGCTCAGGTCAGTGATG-3’ (reverse); for the PU.1
gene: 5’-CAGCTCTACCGCCACATGGA-3’ (forward) and 5’-
TAGGAGACCTGGTGGCCAAGA-3’ (reverse); for the C/
EBPB gene: 5’-AACTCTCTGCTTCTCCCTCTG-3’ (forward)
and 5’-AAGCCCGTAGGAACATCTTT-3’ (reverse); for the
TBP gene: 5’-TCTGGGATTGTACCGCAGC-3’ (forward) and
5’-CGAAGTGCAATGGTCTTTAGG-3’ (reverse); for the GA-
PDH gene: 5’-GCACCGTCAAGGCTGAGAAC-3’ (forward)
and 5’-TGGTGAAGACGCCAGTGGA-3’ (reverse).
Measurement of secreted cytokine by ELISA
The levels of IL-1b, IL-1Ra, IFN-c, IL-17A in the supernatants
of stimulated PBMCs or CD14+ monocytes were determined using
commercially available ELISA kits (R&D, Minneapolis, MN),
following the manufacturer’s instructions.
Plasmid constructs
The human IL1B promoter (21292 to +79) was amplified by
PCR and inserted into pGL3-Basic vector (Promega) upstream of
the firefly luciferase coding region at XhoI and NcoI sites. Positive
clones were subjected to site-directed mutagenesis using Quick
Change Site-Directed mutagenesis Kit (Stratagene, La Jolla, CA)
to obtain the desired alleles. Expression vectors for the full-length
PU.1 and C/EBPB were constructed by inserting the respective
coding regions into pcDNA3.1 expression vector (life technology,
Carlsbad, CA) at XhoI and EcoRI sites. The primer used for
cloning were as follows: for PU.1, 5’-TATCTCGAGAACT-
TGTGCTGGCCCTGCAATG-3’ (forward) and 5’-TATGAAT-
TCTGTGGGGCGGGTGGCGCCGCT-3’ (reverse); for C/
EBPB, 5’-TATCTCGAGGAGTCAGAGCCGCGCACGGGA-
CT-3’ (forward) and 5’-TATGAATTCTGCAGTGGCCGGAG-
GAGGCGAGCAGGGGCT-3’ (reverse).
Transfection and dual-luciferase assay
HeLa cells (26105) were plated in 24-well plates 24 h before
transfection. A total of 0.8 ug plasmid DNA including 0.3 ug of
either rs1143627 T or rs1143627 C reporter vector, 0.2 mg of
pcDNA3.1-PU.1 or pcDNA3.1-C/EBPB expression vector, and
0.1 mg of pRL-TK control vector, were co-transfected into the
cells using Lipofectamine 2000 reagent (life technology). Cells
were stimulated by PMA (50 ng/ml) for 20 h, following 24 h of
transfection. Cells were then harvested and lysed in 150 uL
passive lysis buffer (Promega), the lysates were assayed for both
the firefly and Renilla luciferase activities using the dual-
luciferase reporter assay system (Promega). Promoter activity
was measured as the ratio between firefly and Renilla luciferase.
The transfection for each construct was performed three times
and each construct was assayed for promoter activity in
duplicates.
Western blotting
HeLa cells transfected with plasmid expressing PU.1 or C/
EBPb were collected 16–20 h after transfection. The cells pellet
was lysed using lysis buffer (10 mM Tris, pH 7.5, 150 mM NaCl,
1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 0.2 mM
sodium orthovanadate, 0.5% Nonidet P-40) supplemented with a
cocktail of protease inhibitors (Sigma-Aldrich, Steinheim, Ger-
many). The lysates were separated by SDS-PAGE on a 12%
polyacrylamide gel and then transferred onto a polyvinylidene
difluoride membrane. The membranes were sequentially probed
with the respective primary antibodies, followed by appropriate
HRP-conjugated secondary antibodies (Promega, Madison, WI)
and then visualized by exposure to X-ray films.
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Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from U937 monocytes as
reported previously [70]. Two sets of complementary DNA-
oligonucleotide sequences containing IL1B rs1143627 C or T
allele were designed and biotin-labelled or left unlabelled (Life
technology). The oligonucleotides used were as follows:
rs1143627C variant, 5’-CCTACTTCTGCTTTTGAAAGCCA-
TAAAAACAGCGA GGGAGAAA-3’; and rs1143627T variant,
5’-CCTACTTCTGCTTTTGA AAGCTATAAAAACAGCGA-
GGAGAAA-3’. Equimolar amounts of each strand were com-
bined in annealing buffer (10 mM Tris, 1 mM EDTA and 50 mM
NaCl) by heating to 95uC for 2 min, and cooling slowly to room
temperature over 2 h. EMSA assays were performed by using the
LightShift chemiluminescent EMSA kit (Pierce, Rockford, IL).
Binding reactions contained 20fmol biotin-labelled double-
stranded probe, 2.0 uL nuclear extract and 1.0 ug poly (dI:dC)
in a total volume of 20 uL binding buffer (10 mM Tris, 50 mM
KCl, 3 mM MgCl2, 0.1 mM EDTA and 1.0 mM DTT). After
incubation for 20 min at room temperature, complexes were
separated on a 6% native polyacrylamide gel, and blotted onto a
positively charged nylon membrane (Millipore, Billerica, MA), and
visualized by exposure to X-ray films. EMSA images were
quantified by densitometry using Quantity One, version 4.5,
software (Bio-Rad). For relative quantification, the integrated
optical density value was determined with background values
taken below each band of interest to account for non-specific
antibody staining in the lane.
For competition experiments, a 200-fold molar excess of
unlabelled probe was added prior to addition of labeled probe.
To assess the putative binding sites within the IL1B promoter in
the region encompassing the SNP rs1143627, we used two
bioinformatic tools, AliBaba2 and TFSearch, to predict the
interaction of the different probes with proteins and set the cutoff
for the dissimilarity matrix at 15%. In antibody supershift assays,
anti-ZEB1, MEF2, C/EBPa, C/EBPb, PU.1, TBP, and SP1 (each
at the final concentration of 1 ug/mL, Santa Cruz Biotechnology,
Santa Cruz, CA) were added after binding of nuclear extracts to
labeled probe and incubated for 20 min at room temperature.
IFN-c ELISPOT assay
A previously established in-house IFN-c ELISPOT assay was
used to measure Mtb antigen specific IFN-c spot forming cells
(SFCs) in peripheral blood samples from patients with TB [41,42].
Briefly, a total of 26105 cells/well of PBMCs were cultured in
duplicate in 96-well plates in the presence of ESAT6 protein
(protein) or peptide pools derived from ESAT6/CFP10 (peptides)
for 24 h. PBMCs cultured in medium alone or in the presence of
phytohemagglutinin (Sigma) at 2.5 ug/ml were used as negative or
positive controls, respectively. IFN-c producing cells were
visualized as spot forming cells after incubation with biotinylated
anti–IFN-cmonoclonal antibody (eBioscience) for 4 h, followed by
streptavidin-alkaline phosphatase conjugate for 2 h and then
substrate solution. The number of SFCs was counted using an
automated ELISPOT reader (BioReader 4000 Pro-X; Biosys,
Germany). The number of SFCs to protein and peptides was
expressed as the number of SFCs per 0.2 million PBMCs. The
background number of SFCs in the negative control well was
subtracted.
Lentiviral-mediated RNA interference
For knockdown of PU.1, or C/EBPB, we used lentiviral vectors
expressing gene-specific small interfering RNA (siRNA) to
specifically block expression. Oligonucleotide sequences of PU.1
and C/EBPB specific siRNAs were as follows: PU.1 siRNA,
5’-GCTTCGCCGAGAACAACTTCA-3’, C/EBPB siRNA, 5’-
TTCTCCGAACGTGTCACGTTTC-3’. The stem-loop oligo-
nucleotides were synthesized and cloned into a lentivirus-based
vector carrying the green fluorescent protein (GFP) gene
(pGCSIL-GFP, Genechem, Shanghai, China). A universal se-
quence (LV1-NC: 5’-TTCTCCGAACGT GTCACGT-3’) was
used as a negative control for RNA interference. Individual
human shRNA lentiviral clones were prepared and isolated as
previously described [71]. For infection with siRNA-carrying
lentiviral vector constructs, the viruses were diluted in serum-free
OptiMEM (life technonogy) and cells were infected at a
multiplicity of infection of 10 for 3 h in the presence of 5 ug/
mL polybrene. After 48 h of infection in serum-containing
medium, cells were harvested and tested for PU.1 or C/EBPb
expression by Western-blot.
Statistical analysis
The Hardy-Weinberg Equilibrium (HWE) for IL1B polymor-
phisms distribution was analyzed in healthy controls and cases.
The allelic and genotypic frequencies of SNPs between cases and
controls were compared using the Pearson X2 test. The
unconditional logistic regression adjusted by gender and age were
performed to calculate the Odd ratios (ORs), 95% confidence
intervals (CIs) and corresponding P values under four alternative
models (multiplicative, additive, dominant and recessive). The
one-way analysis of variance (ANOVA)/Newman-Keuls multiple
comparison test was used for statistical analyses to compare the
differences among multiple groups. The paired t test was used to
compare the IFN-c production with or without treatment of anti-
IL-1b. Correlations were assessed using Spearman’s rank corre-
lation, and Pearson’s t test was used to analyze the correlation. We
used GraphPad Prism software (version 4.0) for all the statistic
analysis. Two-tailed statistical tests were conducted with a
significance level of 0.05.
Accession numbers of genes mentioned in the
manuscript
IL1B: [Homo sapiens (human)]. NCBI Gene ID: 3553.
C/EBPB: [Homo sapiens (human)]. NCBI Gene ID: 1051.
PU.1: [Homo sapiens (human)]. NCBI Gene ID: 6688.
TBP: [Homo sapiens (human)]. NCBI Gene ID: 6908.
IL1RN: [Homo sapiens (human)]. NCBI Gene ID: 3557.
Supporting Information
Figure S1 Association between IL1B SNP and ESR/CRP
levels in the peripheral blood. The ESR (A and B) and CRP (C
and D) levels were determined in a total of 831 and 556
patients with pulmonary TB before initiation of anti-TB
chemotherapy, respectively. The ESR levels in patients
carrying different rs1143627 genotypes (A) or rs16944 geno-
types (B). The CRP levels in patients carrying differ-
entrs1143627 genotypes (C) or rs16944 genotypes (D). The
differences among groups were compared using one-way
ANOVA/Newman-Keuls multiple comparison test, no signif-
icant difference was found.
(TIF)
Figure S2 IL-1b promotes IFN-c, but not IL-17A, production.
PBMCs from healthy controls carrying different rs1143627
genotypes (TT, n= 24; TC, n= 24; CC, n= 24) were cultured in
the absence or presence of heat killed Mtb lysate (20 mg/mL) for
48 h. The concentrations of secreted IL-1b, IFN-c and IL-17A
were determined by ELISA. Correlation analysis between the
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levels of IFN-c (A) or IL-17A (C) and IL-1b was performed. The
coefficient r and p value were indicated. PBMCs isolated from
healthy controls were cultured in the same protocol as described
above (A), without or with the addition of anti-IL1b (B) or
exogenous IL-1b (D) at final concentration of 20 ug/ml. The levels
IFN-c in the supernatants were determined by ELISA. The
difference of IFN-c production between without and with
treatment were compared by paired t-test, P value was indicated.
* p,0.05.
(TIF)
Figure S3 Association between rs16944 SNP and Mtb-specific
IFN-c production. ESAT-6 protein (A, indicated as protein) and
ESAT-6/CFP-10 peptides pool (B, indicated as peptides) specific
IFN-c production by PBMCs from patients with PTB carrying
different rs16944 genotypes (AA, n= 209; AG, n= 410; and GG,
n=255) were detected by ELISPOT assay. Data were expressed
the number of IFN-c SFCs per 26105 PBMCs of each subjects.
The differences among groups were compared using one-way
ANOVA/Newman-Keuls multiple comparison test, no significant
difference was found.
(TIF)
Table S1 Association between rs1143627 SNP and TB suscep-
tibility in Shenzhen and Shanghai cohort.
(DOC)
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